Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
New YORK—DDB Worldwide has landed ad duties on Singulair, an anti-asthma drug from Merck & Co., the client comfirmed. Billings are estimated at more than $40 million.
DDB bested fellow New York shops McCann-Erickson Worldwide, J. Walter Thompson and FCB Worldwide. FCB was the incumbent.
The assignment encompasses creative and media planning duties for the prescription drug, which is sold in tablet form. Media duties on all Merck brands are consolidated at TN Media, here.
Spending on Singulair has exploded from less than $1 million in 1998 to more than $40 million in the first 10 months of 2000, according to Competitive Media Reporting.
As part of the brief, the shops were asked to develop a budget for 2001, sources said.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in